16:02 Dec 20
Sanofi India Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Sanofi India Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
45/100
Medium Financial Strength
Valuation
23/100
Expensive Valuation
Technical
41/100
Technically Neutral
Strength
2
Weakness
6
Opportunity
0
Threats
1
59.38 %
ROE %
35.15 %
ROA %
199.60
EPS
441.39
BVPS
21.14 %
Net Profit Margin
| Dec 2023 | TTM 2024 | ||
|---|---|---|---|
| Net Sales | 2851.1 | 2413.8 | |
| Operating Expenses + | 2047.4 | 1772.11 | |
| Raw Material | 1493.4 | 922.1 | |
| Increase Decrease in Cost | -292.4 | 147.67 | |
| Other Manufacturing Expense | 0 | 0 | |
| Employee Cost | 370.6 | 301.2 | |
| Miscellaneous Expenses | 2333.8 | 401.14 | |
| Operating Profit | 803.7 | 641.69 | |
| Other Income | 65.3 | 25.6 | |
| Depreciation | 39.6 | 38.2 | |
| Interest | 1.7 | 1.5 | |
| Profit before tax and exceptio.. | 827.7 | 627.59 | |
| Exceptional Items | 17.8 | -45.7 | |
| PBT | 845.5 | 673.29 | |
| Provision for Taxation | 242.6 | 157.2 | |
| Net Profit | 602.9 | 459.69 | |
| NET Profit after MI | 602.9 | 459.69 | |
| EPS | 261.78 | 199.6 | |
| Operating Profit Margin (%) | 28.19 | 26.58 | |
| Net Profit Margin (%) | 21.15 | 19.04 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Promoter | 60.40 | 60.40 | 60.40 | 60.40 | 60.40 |
| FII | 5.80 | 5.80 | 6.10 | 6.30 | 6.80 |
| MF | 11.60 | 11.60 | 11.70 | 11.50 | 10.00 |
| Public | 11.00 | 11.00 | 10.40 | 12.30 | 11.10 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Others | 11.20 | 11.20 | 11.40 | 9.50 | 11.70 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
